drugset / Trial / NCT04443920

Tranexamic Acid for Total Knee Arthroscopy

NCT04443920

Phase 4 Completed 86 enrolled The Miriam Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this investigation is to determine the most effective regimen of administration of tranexamic acid to improve clinical outcome among patients undergoing total knee arthroplasty.

Timeline

Start
2019-10-29
Primary completion
2020-10-07
Completion
2021-01-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 15 mg/kg Intravenous

Indications

No indication recorded.